Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
US12329726B2 · kind B2 · utility
0Cited by
8References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 28, 2022 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Dec 20, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biomarkers for assessing the efficacy of prophylactic treatments of stress-induced affective disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.